Exelixis
EXEL
#1558
Rank
A$19.87 B
Marketcap
A$80.20
Share price
0.47%
Change (1 day)
37.51%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company